157 related articles for article (PubMed ID: 34158464)
1. Outcomes After TIPS for Ascites and Variceal Bleeding in a Contemporary Era-An ALTA Group Study.
Boike JR; Mazumder NR; Kolli KP; Ge J; German M; Jest N; Morelli G; Spengler E; Said A; Lai JC; Desai AP; Couri T; Paul S; Frenette C; Verna EC; Rahim U; Goel A; Gregory D; Thornburg B; VanWagner LB;
Am J Gastroenterol; 2021 Oct; 116(10):2079-2088. PubMed ID: 34158464
[TBL] [Abstract][Full Text] [Related]
2. Decision making for transjugular intrahepatic portosystemic stent shunt in refractory ascites and variceal bleeding: MELD, or not MELD, that is the question.
Pitton MB; Zimmermann T; Mildenberger P; Weinmann A; Kloeckner R; Düber C; Mittler J; Hoppe-Lotichius M; Otto G
Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e214-e222. PubMed ID: 33230020
[TBL] [Abstract][Full Text] [Related]
3. Long-term effects and complications of the transjugular intrahepatic portosystemic shunt: a single-centre experience.
Kraglund F; Jepsen P; Amanavicius N; Aagaard NK
Scand J Gastroenterol; 2019 Jul; 54(7):899-904. PubMed ID: 31203699
[No Abstract] [Full Text] [Related]
4. Long-term clinical outcome and survival predictors in patients with cirrhosis after 10-mm-covered transjugular intrahepatic portosystemic shunt.
Tejedor-Tejada J; Fuentes-Valenzuela E; García-Pajares F; Nájera-Muñoz R; Almohalla-Álvarez C; Sánchez-Martín F; Calero-Aguilar H; Villacastín-Ruiz E; Pintado-Garrido R; Sánchez-Antolín G
Gastroenterol Hepatol; 2021 Nov; 44(9):620-627. PubMed ID: 33249114
[TBL] [Abstract][Full Text] [Related]
5. Early TIPS with covered stents versus standard treatment for acute variceal bleeding in patients with advanced cirrhosis: a randomised controlled trial.
Lv Y; Yang Z; Liu L; Li K; He C; Wang Z; Bai W; Guo W; Yu T; Yuan X; Zhang H; Xie H; Yao L; Wang J; Li T; Wang Q; Chen H; Wang E; Xia D; Luo B; Li X; Yuan J; Han N; Zhu Y; Niu J; Cai H; Xia J; Yin Z; Wu K; Fan D; Han G;
Lancet Gastroenterol Hepatol; 2019 Aug; 4(8):587-598. PubMed ID: 31153882
[TBL] [Abstract][Full Text] [Related]
6. Differences in long-term survival after transjugular intrahepatic portosystemic shunt for refractory ascites and variceal bleed.
Membreno F; Baez AL; Pandula R; Walser E; Lau DT
J Gastroenterol Hepatol; 2005 Mar; 20(3):474-81. PubMed ID: 15740494
[TBL] [Abstract][Full Text] [Related]
7. Incrementally Expandable Transjugular Intrahepatic Portosystemic Shunts: Single-Center Experience.
Cui J; Smolinski SE; Liu F; Xu D; Dulaimy K; Irani Z
AJR Am J Roentgenol; 2018 Feb; 210(2):438-446. PubMed ID: 29261352
[TBL] [Abstract][Full Text] [Related]
8. Refining prediction of survival after TIPS with the novel Freiburg index of post-TIPS survival.
Bettinger D; Sturm L; Pfaff L; Hahn F; Kloeckner R; Volkwein L; Praktiknjo M; Lv Y; Han G; Huber JP; Boettler T; Reincke M; Klinger C; Caca K; Heinzow H; Seifert LL; Weiss KH; Rupp C; Piecha F; Kluwe J; Zipprich A; Luxenburger H; Neumann-Haefelin C; Schmidt A; Jansen C; Meyer C; Uschner FE; Brol MJ; Trebicka J; Rössle M; Thimme R; Schultheiss M
J Hepatol; 2021 Jun; 74(6):1362-1372. PubMed ID: 33508376
[TBL] [Abstract][Full Text] [Related]
9. Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: a Meta-analysis of Individual Patient Data.
Nicoară-Farcău O; Han G; Rudler M; Angrisani D; Monescillo A; Torres F; Casanovas G; Bosch J; Lv Y; Thabut D; Fan D; Hernández-Gea V; García-Pagán JC;
Gastroenterology; 2021 Jan; 160(1):193-205.e10. PubMed ID: 32980344
[TBL] [Abstract][Full Text] [Related]
10. Evolving Indications for Tips.
Smith M; Durham J
Tech Vasc Interv Radiol; 2016 Mar; 19(1):36-41. PubMed ID: 26997087
[TBL] [Abstract][Full Text] [Related]
11. Factors influencing in-hospital mortality for salvage percutaneous transjugular intrahepatic portosystemic shunting in cirrhotic patients with recalcitrant variceal bleeding after failed endoscopic intervention.
Krige JEJ; Jonas EG; Setshedi M; Beningfield SJ; Lotze UK; Bernon MM; Burmeister S; Kloppers JC
S Afr Med J; 2023 Dec; 114(1):39-43. PubMed ID: 38525611
[TBL] [Abstract][Full Text] [Related]
12. Transjugular Intrahepatic Porto-Systemic Shunt in Patients with Liver Cirrhosis and Model for End-Stage Liver Disease ≥15.
Ascha M; Hanouneh M; S Ascha M; Zein NN; Sands M; Lopez R; Hanouneh IA
Dig Dis Sci; 2017 Feb; 62(2):534-542. PubMed ID: 27154510
[TBL] [Abstract][Full Text] [Related]
13. Transjugular intrahepatic portosystemic shunt--role in treating intractable variceal bleeding, ascites, and hepatic hydrothorax.
LaBerge JM
Clin Liver Dis; 2006 Aug; 10(3):583-98, ix. PubMed ID: 17162229
[TBL] [Abstract][Full Text] [Related]
14. Characteristics and outcomes of transjugular intrahepatic portosystemic shunt recipients in the VA Healthcare System.
Lerrigo R; Beste LA; Leipertz SL; Green PK; Lok AS; Kogut MJ; Ioannou GN
Eur J Gastroenterol Hepatol; 2016 Jun; 28(6):667-75. PubMed ID: 26886386
[TBL] [Abstract][Full Text] [Related]
15. Identifying optimal candidates for early TIPS among patients with cirrhosis and acute variceal bleeding: a multicentre observational study.
Lv Y; Zuo L; Zhu X; Zhao J; Xue H; Jiang Z; Zhuge Y; Zhang C; Sun J; Ding P; Ren W; Li Y; Zhang K; Zhang W; He C; Zhong J; Peng Q; Ma F; Luo J; Zhang M; Wang G; Sun M; Dong J; Bai W; Guo W; Wang Q; Yuan X; Wang Z; Yu T; Luo B; Li X; Yuan J; Han N; Zhu Y; Niu J; Li K; Yin Z; Nie Y; Fan D; Han G
Gut; 2019 Jul; 68(7):1297-1310. PubMed ID: 30415233
[TBL] [Abstract][Full Text] [Related]
16. Applying the original model for end-stage liver disease score rather than the model for end-stage liver disease-Na score for risk stratification prior to transjugular intrahepatic portosystemic shunt procedures.
Lee BT; Yang AH; Urban S; Kim KY; Ter-Oganesyan R; Yuan L; Han HH; Khemichian S; Kahn JA; Kim B
Eur J Gastroenterol Hepatol; 2021 Apr; 33(4):541-546. PubMed ID: 32398491
[TBL] [Abstract][Full Text] [Related]
17. Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage.
Sahagun G; Benner KG; Saxon R; Barton RE; Rabkin J; Keller FS; Rosch J
Am J Gastroenterol; 1997 Sep; 92(9):1444-52. PubMed ID: 9317060
[TBL] [Abstract][Full Text] [Related]
18. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
Colombato L
J Clin Gastroenterol; 2007; 41 Suppl 3():S344-51. PubMed ID: 17975487
[TBL] [Abstract][Full Text] [Related]
19. Transjugular Intrahepatic Portosystemic Shunt (TIPS): Pathophysiologic Basics, Actual Indications and Results with Review of the Literature.
Strunk H; Marinova M
Rofo; 2018 Aug; 190(8):701-711. PubMed ID: 30045395
[TBL] [Abstract][Full Text] [Related]
20. Transjugular intrahepatic portosystemic shunt (TIPS) placement at index portal hypertensive decompensation (anticipant TIPS) in cirrhosis and the role of early intervention in variceal bleeding and ascites.
Rajesh S; Philips CA; Betgeri SS; George T; Ahamed R; Mohanan M; Augustine P
Indian J Gastroenterol; 2021 Aug; 40(4):361-372. PubMed ID: 34324168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
